Trading Summary - October 31. Another satisfactory

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
230
Trading Summary - October 31.

Another satisfactory status quo day for $DIGX as the countdown to the pre-Q3 loading run continues.

Nobody duped to sell at .0003 or .0004 by the fake stacked ask and the insignificant paint downs at .0004 and .0003. Any undercut ask .0004s were bought out putting the .0005s up again.

Another 4M loaded today at .0004/5.

The whales and many of my followers are still concentrating on loading bottom range prices on 3 other alerted stocks which are likely to run this week. Thereafter, multiple $5-figure sums will be available to add $DIGX at any price that makes sense for the Q3 and Q4 runs.

As has been evident for several weeks now, nobody is going to get any significant amount of .0003s before the next run.

The real ask from MMs other than NITE at .0005 was the same at around 14M. It remains to be see how much of the NITE figure is fake and will be pulled when hit hard. 50M has been bought out before and can be again if necessary.

Only 10 trading days remain now to the filing of the Q3 Report (due November 15) - with demand-led pre-runs usually happening beforehand.

Stay sharp if you don't already have all the shares you need to make your profit expectations. Prior warning and / or scanner alerts will not be given on iHub.

Watch closely from now on - continuously if you can - to see if a few of the at least 4 whales known to be in $DIGX decide to take out the .0005s as one did with the .0004s yesterday.

Those that fail to cancel any sell orders at .0005 can expect to lose their shares within seconds / minutes at some point in the coming days / weeks - with probably the same people buying as prior to Q1 & Q2. Timing is likely to depend on whether other picks common to the main buyers are running or not on any particular day - as several are in the frame over the next 1 to 8 weeks with PRs and filings starting to roll out. At least 3 of these have updates due tomorrow - during the trading day or after the close.

Content below the line mainly unchanged from last update - relevant to those that are new here.

There are at least 4 x whales who trade $DIGX continuously throughout each year who will be happy to take around 20M each if anyone is stupid or impatient enough to sell for a loss at any level below the current one. Any shares bought at .0004 will be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q3 and Q4. Shares bought at .0005 should easily return 100%+ at some point.

In my experience, 70M>100M is the optimum amount to take best advantage of each run whilst keeping the 25M cheapest batches for the bigger runs next year (especially Q4 in March 2018 when the full year profits will be up). My cheapest 25M retained for next year will not require any shares bought above .0004 now so all others will be tradeable for up to 100% during the remaining runs in 2017.

Expect the status quo to be maintained until the next pre-Q3 run, with it making little difference to long-term traders whether shares are picked up at .0004/5/6 - they will see a profit on all of them by Q3 / Q4 and on various runs between. the big boys in DIGX will probably be aiming to have an inventory of 50M>120M (based on near instantaneous loading seen across 2 price points in seconds when coming off the inter-Q bottom before).

Also expect an element of the .0003 bidders - particularly those unlikely to fill on paint downs in the time remaining before the next run prior to Q3 at latest - to continue to buy .0004s and .0005s whilst they are still available. Only 33% of the bid at .0003 hitting the ask at .0005 would be sufficient to take out even the current fake ask if left there.

We can now look forward to additional updates on both the possible merger discussed recently and the implementation of the additional services being offered in the chiropractic chain offices - per the Strategic Growth Plan announced earlier - over the coming days, weeks and months..

The long whales will continue to buy at all prices that makes sense to them at any given point to have a cache for trading on any demand led run, the Q3 and through to the Annual Report in March 2018.

$DIGX will most likely not be allowed to go to previous year-end or inter-Q lows.

In my opinion, nobody has bought $DIGX in 2017 at a price that it isn't likely to exceed in the coming months (2017 high .0013) through to the Annual Report (March 2018).

Ludicrous claims by the notorious bashers currently on iHub - "RFB", "munimi", "Crown Capital" and "surfkast" - are clearly seen as such by all serious traders and now even by most short term (next Q) iHubbers.

Debunking nonsense posted by morons on iHub, there is absolutely no need or intention to do a reverse split. The share structure is exceptionally thin - with no dilution - and the company has been buying back shares. OTC market specialists who trade $DIGX continuously would not be loading 50M>100M shares at these inter-Q bottom prices to trade over the next 6 months if there was even the remote possibility of a reverse split.

Regardless of whether iHub posters lose interest over the coming days and weeks, detailed coverage will continue here as $DIGX remains one of my top picks for repeat profits for those that are patient and trade it to best effect (keep all cheapest batches of shares - create an inventory of shares at higher prices to trade on every run - big or small).

In addition, money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.




American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 83

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 258

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 116

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 153

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

The Future of Hybrid Powertrains: Market Insights and Forecast

Updated Category News Views 309

Overview of the Hybrid Powertrain Market The Hybrid Powertrain Market is set for remarkable growth over the next decade, driven by a surge in demand for eco-friendly, fuel-efficient vehicles globally. Industry experts highlight the innovative strides made by prominent players like Hyundai Motor Company, Honda Motor Co., Ltd., Ford Motor Company, and Toyota Motor...

Continue Reading
Discover the Unique Aston Martin Valkyrie Auctioned by Ricciardo

Updated Category News Views 227

Aston Martin Valkyrie: A Hypercar Marvel Broad Arrow Auctions is set to showcase an exceptional hypercar, the Aston Martin Valkyrie, at its inaugural Zoute Concours Auction. This stunning vehicle was personally commissioned and driven by the celebrated Formula One driver, Daniel Ricciardo. Not only is this Valkyrie a piece of automotive artwork, but it also holds a rich...

Continue Reading
Defense Mobility Lifted as Rubber Tracks Gain Traction

Updated Category News Views 36

Rubber Tracks Are Shaping Tomorrow’s Battlefields Defense agencies, faced with a world that's perpetually bristling with tension, need solutions that are light on their feet—literally. As luck would have it, rubber track technology seems to be offering just what the tactical doctor ordered, paving the way for a chunk of the defense sector to trot steadily towards a...

Continue Reading
Strategic Partnership to Transform Auto Insurance Industry

Updated Category News Views 77

YSX TECH. CO., LTD Forms Strategic Alliance with Huijian YSX TECH. CO., LTD (NASDAQ: YSXT), a notable entity providing comprehensive business solutions primarily for insurance firms in China, has recently embarked on an exciting venture with Huijian Information Technology Co., Ltd. This strategic alliance marks a significant move in the realm of auto insurance and supply...

Continue Reading
Peabody Class Action: Investors Eye Lead Role

Updated Category News Views 57

Peabody Energy Awash in Legal Turmoil There’s a storm brewing over at Peabody Energy, and it’s not coal dust causing the ruckus this time. Investors are eyeing an opportunity to step into the driver’s seat of a class action lawsuit, pointing fingers at Peabody for alleged securities law violations. If you got your skin scorched between October 14, 2024, and May 4,...

Continue Reading